RAM
NVO

Ramirez Asset Management’s Novo Nordisk NVO Stock Holding History

Ramirez Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-27,948
Closed -$1.93M – 364
2025
Q2 		$1.93M Buy
27,948
+5,826
+26% +$396K 0.29% 101
2025
Q1 		$1.54M Sell
22,122
-211
-0.9% -$17.4K 0.32% 89
2024
Q4 		$1.92M Sell
22,333
-317
-1% -$34.3K 0.39% 75
2024
Q3 		$2.7M Buy
22,650
+42
+0.2% +$5.6K 0.52% 60
2024
Q2 		$3.23M Sell
22,608
-1,018
-4% -$135K 0.66% 53
2024
Q1 		$3.03M Buy
23,626
+7,354
+45% +$875K 0.61% 61
2023
Q4 		$1.68M Buy
+16,272
New +$1.61M 0.34% 94

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ramirez Asset Management's NVO Position: Q3 2025 in Review

Ramirez Asset Management sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 27,948 shares — an estimated $1.93M sold.

Ramirez Asset Management first reported a position in NVO in Q4 2023 and held it in 7 quarters. The position peaked at $3.23M in Q2 2024. 1,398 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Ramirez Asset Management reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Ramirez Asset Management sold 27,948 Novo Nordisk shares in Q3 2025, an estimated $1.93M.
  • Ramirez Asset Management first reported a position in Novo Nordisk in Q4 2023 and held it in 7 quarters.
  • Ramirez Asset Management's Novo Nordisk position peaked at $3.23M in Q2 2024.
  • 1,398 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Ramirez Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.